Published in Hum Mol Genet on April 01, 1992
Transgenic expression of {alpha}7{beta}1 integrin maintains muscle integrity, increases regenerative capacity, promotes hypertrophy, and reduces cardiomyopathy in dystrophic mice. Am J Pathol (2005) 1.37
Preservation of muscle force in Mdx3cv mice correlates with low-level expression of a near full-length dystrophin protein. Am J Pathol (2008) 1.33
Physiological characterization of muscle strength with variable levels of dystrophin restoration in mdx mice following local antisense therapy. Mol Ther (2010) 1.20
Functional rescue of dystrophin-deficient mdx mice by a chimeric peptide-PMO. Mol Ther (2010) 1.10
How much dystrophin is enough: the physiological consequences of different levels of dystrophin in the mdx mouse. Hum Mol Genet (2015) 1.07
Integrated study of 100 patients with Xp21 linked muscular dystrophy using clinical, genetic, immunochemical, and histopathological data. Part 1. Trends across the clinical groups. J Med Genet (1993) 0.96
Integrated study of 100 patients with Xp21 linked muscular dystrophy using clinical, genetic, immunochemical, and histopathological data. Part 2. Correlations within individual patients. J Med Genet (1993) 0.91
Genetic correction of dystrophin deficiency and skeletal muscle remodeling in adult MDX mouse via transplantation of retroviral producer cells. J Clin Invest (1997) 0.79
A marginal level of dystrophin partially ameliorates hindlimb muscle passive mechanical properties in dystrophin-null mice. Muscle Nerve (2012) 0.79
Linkage relationship of a cloned DNA sequence on the short arm of the X chromosome to Duchenne muscular dystrophy. Nature (1982) 11.57
Linkage analysis of two cloned DNA sequences flanking the Duchenne muscular dystrophy locus on the short arm of the human X chromosome. Nucleic Acids Res (1983) 8.92
A highly polymorphic DNA marker linked to adult polycystic kidney disease on chromosome 16. Nature (1985) 7.34
Cloning of a representative genomic library of the human X chromosome after sorting by flow cytometry. Nature (1981) 6.18
Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature (1993) 5.81
Utrophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy. Cell (1997) 4.38
Analysis of deletions in DNA from patients with Becker and Duchenne muscular dystrophy. Nature (1986) 4.13
Monoclonal antibody to a plasma membrane antigen of neurons. Proc Natl Acad Sci U S A (1979) 4.09
Very mild muscular dystrophy associated with the deletion of 46% of dystrophin. Nature (1990) 3.84
Identification of a novel aspartic protease (Asp 2) as beta-secretase. Mol Cell Neurosci (1999) 3.77
A novel role for myelin-associated glycoprotein as an inhibitor of axonal regeneration. Neuron (1994) 3.57
Genetic mapping of chronic childhood-onset spinal muscular atrophy to chromosome 5q11.2-13.3. Nature (1990) 3.48
Physiological and structural changes in the cat's soleus muscle due to immobilization at different lengths by plaster casts. J Physiol (1972) 3.42
Report of the committee on the genetic constitution of the X chromosome. Cytogenet Cell Genet (1989) 3.37
International SMA consortium meeting. (26-28 June 1992, Bonn, Germany). Neuromuscul Disord (1992) 3.26
Prenatal diagnosis and carrier detection of Duchenne muscular dystrophy with closely linked RFLPs. Lancet (1985) 3.08
Report of the Committee on the Genetic Constitution of the X and Y Chromosomes. Cytogenet Cell Genet (1985) 3.07
Human dystrophin expression in mdx mice after intramuscular injection of DNA constructs. Nature (1991) 3.03
Longitudinal growth of striated muscle fibres. J Cell Sci (1971) 2.95
Amelioration of the dystrophic phenotype of mdx mice using a truncated utrophin transgene. Nature (1996) 2.95
An autosomal transcript in skeletal muscle with homology to dystrophin. Nature (1989) 2.91
Inhibitor of neurite outgrowth in humans. Nature (2000) 2.89
The positions of three restriction fragment length polymorphisms on chromosome 4 relative to known genetic markers. Hum Genet (1984) 2.84
Further studies of gene deletions that cause Duchenne and Becker muscular dystrophies. Genomics (1988) 2.74
Preferential deletion of exons in Duchenne and Becker muscular dystrophies. Nature (1987) 2.67
Sarcomere length during post-natal growth of mammalian muscle fibres. J Cell Sci (1968) 2.62
Deletions in the survival motor neuron gene on 5q13 in autosomal recessive spinal muscular atrophy. Hum Mol Genet (1995) 2.59
Toward a complete linkage map of the human X chromosome: regional assignment of 16 cloned single-copy DNA sequences employing a panel of somatic cell hybrids. Am J Hum Genet (1984) 2.58
The effect of immobilization on the longitudinal growth of striated muscle fibres. J Anat (1973) 2.57
A mutation in the alpha tropomyosin gene TPM3 associated with autosomal dominant nemaline myopathy. Nat Genet (1995) 2.57
Structural mosaicism on the submicron scale in the plasma membrane. Biophys J (1998) 2.50
The use of linked DNA polymorphisms for genotype prediction in families with Duchenne muscular dystrophy. J Med Genet (1983) 2.45
PDZ domains: targeting signalling molecules to sub-membranous sites. Bioessays (1997) 2.39
Muscle fibre growth in five different muscles in both sexes of mice. J Anat (1969) 2.36
Physical mapping studies on the human X chromosome in the region Xq27-Xqter. Genomics (1987) 2.35
Activation of the FGF receptor underlies neurite outgrowth stimulated by L1, N-CAM, and N-cadherin. Neuron (1994) 2.29
Neuropilin-2 is required in vivo for selective axon guidance responses to secreted semaphorins. Neuron (2000) 2.25
Cloning, sequence analysis, and expression of genes encoding xylan-degrading enzymes from the thermophile "Caldocellum saccharolyticum". Appl Environ Microbiol (1990) 2.22
Orientation of cell-surface antigens in the lipid bilayer of lymphocyte plasma membrane. Nature (1977) 2.18
Oligodendrocyte population dynamics and the role of PDGF in vivo. Neuron (1998) 2.11
Primary structure of dystrophin-related protein. Nature (1992) 2.09
Expression of IGF-I splice variants in young and old human skeletal muscle after high resistance exercise. J Physiol (2002) 2.09
Effective strategy for prenatal prediction of Duchenne and Becker muscular dystrophy. Lancet (1987) 2.08
Changes in sarcomere length and physiological properties in immobilized muscle. J Anat (1978) 2.08
Modification of splicing in the dystrophin gene in cultured Mdx muscle cells by antisense oligoribonucleotides. Hum Mol Genet (1998) 2.07
Lymphatic mapping and sentinel lymph node biopsy in patients with melanoma of the lower extremity. Plast Reconstr Surg (1999) 2.02
DNA testing for fragile X syndrome in schools for learning difficulties. Arch Dis Child (1995) 1.98
Alternative splicing generates a secreted form of N-CAM in muscle and brain. Cell (1988) 1.97
CAM-FGF receptor interactions: a model for axonal growth. Mol Cell Neurosci (1996) 1.95
Instability versus predictability: the molecular diagnosis of myotonic dystrophy. J Med Genet (1992) 1.94
ZZ and TAZ: new putative zinc fingers in dystrophin and other proteins. Trends Biochem Sci (1996) 1.94
Cloning and characterization of an IGF-1 isoform expressed in skeletal muscle subjected to stretch. J Muscle Res Cell Motil (1996) 1.94
Two genetic markers closely linked to adult polycystic kidney disease on chromosome 16. Br Med J (Clin Res Ed) (1986) 1.93
Linkage studies of X-linked recessive spastic paraplegia using DNA probes. Hum Genet (1986) 1.92
A new DNA marker tightly linked to the fragile X locus (FRAXA). Science (1989) 1.88
Neural cell adhesion molecule (NCAM) is the antigen recognized by monoclonal antibodies of similar specificity in small-cell lung carcinoma and neuroblastoma. Int J Cancer (1989) 1.85
Morphoregulatory activities of NCAM and N-cadherin can be accounted for by G protein-dependent activation of L- and N-type neuronal Ca2+ channels. Cell (1991) 1.85
Immunological studies of yeast nuclear RNA polymerases at the subunit level. J Biol Chem (1980) 1.84
Epithelial (E-) and placental (P-) cadherin cell adhesion molecule expression in breast carcinoma. J Pathol (1993) 1.83
A premutation that generates a defect at crossing over explains the inheritance of fragile X mental retardation. Am J Med Genet (1985) 1.83
Use of a chromosome 21 cloned DNA probe for the analysis of non-disjunction in Down syndrome. Hum Genet (1984) 1.81
Human muscle neural cell adhesion molecule (N-CAM): identification of a muscle-specific sequence in the extracellular domain. Cell (1987) 1.81
Direct interaction between emerin and lamin A. Biochem Biophys Res Commun (2000) 1.77
Prenatal diagnosis of spinal muscular atrophy by gene deletion analysis. Lancet (1995) 1.75
Expression of insulin growth factor-1 splice variants and structural genes in rabbit skeletal muscle induced by stretch and stimulation. J Physiol (1999) 1.74
A microdeletion of less than 250 kb, including the proximal part of the FMR-I gene and the fragile-X site, in a male with the clinical phenotype of fragile-X syndrome. Am J Hum Genet (1992) 1.73
Patterns of exon deletions in Duchenne and Becker muscular dystrophy. Hum Genet (1988) 1.73
Orthostatic hypotension and the Holmes-Adie syndrome. A study of two patients with afferent baroreceptor block. J Neurol Neurosurg Psychiatry (1971) 1.70
Role of myelin P0 protein as a homophilic adhesion molecule. Nature (1990) 1.68
Report of the committee on the genetic constitution of the X and Y chromosomes. Cytogenet Cell Genet (1987) 1.68
Skeletal muscle-specific expression of a utrophin transgene rescues utrophin-dystrophin deficient mice. Nat Genet (1998) 1.68
Muscle satellite (stem) cell activation during local tissue injury and repair. J Anat (2003) 1.67
Missense mutation clustering in the survival motor neuron gene: a role for a conserved tyrosine and glycine rich region of the protein in RNA metabolism? Hum Mol Genet (1997) 1.67
Posthumous diagnosis of long QT syndrome from neonatal screening cards. Heart Rhythm (2010) 1.65
Expression of a dominant negative FGF receptor inhibits axonal growth and FGF receptor phosphorylation stimulated by CAMs. Neuron (1997) 1.64
A cytological map of the human X chromosome--evidence for non-random recombination. Nucleic Acids Res (1984) 1.64
The application of DNA recombinant technology to the analysis of the human genome and genetic disease. Hum Genet (1981) 1.64
Comparative analysis of antisense oligonucleotide sequences for targeted skipping of exon 51 during dystrophin pre-mRNA splicing in human muscle. Hum Gene Ther (2007) 1.63
Sex chromosome positions in human interphase nuclei as studied by in situ hybridization with chromosome specific DNA probes. Hum Genet (1984) 1.62
Utrophin actin binding domain: analysis of actin binding and cellular targeting. J Cell Sci (1995) 1.61
Connective tissue changes in immobilised muscle. J Anat (1984) 1.60
Evidence for collapsin-1 functioning in the control of neural crest migration in both trunk and hindbrain regions. Development (1999) 1.60
Precursor arrays for triplet repeat expansion at the fragile X locus. Hum Mol Genet (1994) 1.59
A muscle-type tropomyosin in human fibroblasts: evidence for expression by an alternative RNA splicing mechanism. Proc Natl Acad Sci U S A (1985) 1.59
Connective tissue changes and physical properties of developing and ageing skeletal muscle. J Anat (1984) 1.57
Linkage studies between polymorphic markers on chromosome 4 and cystic fibrosis. Hum Genet (1985) 1.57
Absence of genetic heterogeneity in Duchenne muscular dystrophy shown by a linkage study using two cloned DNA sequences. J Med Genet (1983) 1.54